A clinical study to evaluate the effect of Shampakadi Kwatha in the management of Vatrakta w.s.r. to Hyperuricemia

Principal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年2月6日

试验速览

暂无简介。

•1) Patients of either gender in the age group between 20-70 years.
•2) Patients having serum uric acid level level more than 7mg/dl (male) and more than 6mg/dl (female) with or without any associated features of joint inflammation.

•1) Patient not willing for the trial.
•2) Patient below age of 20 years and above 70 years of age.
•3) Patient suffering from any other form of arthritis like osteoarthritis, Tubercular arthritis, Rheumatoid etc.
•4) Patient suffering from chronic renal, respiratory, cardiac and hepatic disorders.
•5)Patient having malignant disorder.
•6) Patients who has completed participation in any other clinical trial during the past 3 months.
•7) Any condition which the investigator thinks may comprise with the safety of the subject.

发起方